Like OmniComm Systems, Inc.

announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 8/18/2021 via BusinessWire

Verily Life Sciences, will acquire SignalPath

synopsis: Verily, an Alphabet company focused on life sciences and healthcare, will acquire SignalPath, a clinical trial management system (CTMS) that improves the ease and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
buyer parent: Google
buyer: Verily Life Sciences
Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily's mission is to make the world’s health data useful so that people enjoy healthier lives. The company develops tools to collect and activate health data, and creates interventions to prevent and manage disease. "
target: SignalPath
SignalPath is a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/7/2021 via BusinessWire

Francisco Partners Management LLC, will acquire STARLIMS

synopsis: Francisco Partners is to acquire the STARLIMS informatics product suite and related business assets from Abbott. A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
buyer: Francisco Partners Management LLC
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Francisco Partners has raised approximately $25 billion in committed capital and invested in more than 300 technology companies. "
target parent: Abbott Laboratories
target: STARLIMS (LIMS:$25.24)
A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/11/2021 via Yahoo, Inc.

RxE2, will acquire Habitu Health

synopsis: RxE2, which is bringing the practice of pharmacy to clinical research, has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes.
buyer: RxE2
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists to make clinical trials more accessible to patients, everywhere. "
target: Habitu Health
Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes by providing real-time analyses of a more comprehensive set of patient data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/6/2019 via BNC Analysis

Advarra, will acquire Forte Research Systems

synopsis: Advarra, the premier provider of institutional review board, institutional biosafety committee, and research quality and compliance consulting services, will acquire Forte, the industry's leading provider of standards-based clinical research technology solutions for major academic medical centers, cancer centers, and health systems.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Primus
target: Forte Research Systems
Forte provides software and services in the critical areas of clinical trial management, clinical data management, and research administration for cancer centers, academic medical centers, and health systems. Forte's flagship Clinical Trial Management System, OnCore manages clinical research data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2015 via PR Web

Aris Global LLC, acquired Medsight Solutions Inc.

synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer: Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
target: Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/27/2015 via PR Newswire

genae, acquired e-novex

synopsis: genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced the acquisition of e-novex, a leading provider of electronic data tools that change medical research. e-novex' proprietory Electronic Data Capture (EDC) technology is widely adopted by various types of medical research organizations.
buyer: genae
genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. As a full service CRO and innovative services provider for the medical industries, genae aims at improving health and quality of life. "
target: e-novex
e-novex is a certified web technology company that provides electronic data tools that facilitates medical research. e-capture.net is an intuitive and user-centric EDC platform that features easy data entry, complex validation rules and flexible reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
closed 2/2/2018 via GlobeNewswire

OmniComm Systems, Inc., acquired Algorics

synopsis: OmniComm Systems, Inc., a leading strategic software solutions provider to the life sciences industry, has acquired Algorics, a company that provides innovative risk-based monitoring and clinical analytics solutions and software to the global life sciences industry with consistent and reliable quality.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. "
target: Algorics
Algorics brings together a team of highly experienced software and life science professionals, united behind a single goal: to provide innovative risk-based monitoring and clinical analytics solutions and software to the global life sciences industry with consistent and reliable quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/12/2013 via GlobeNewswire

OmniComm Systems, Inc., acquired Promasys BV

synopsis: OmniComm Systems, Inc., one of the fastest growing companies in the Electronic Data Capture marketplace, announced the acquisition of Promasys BV, a Netherlands based company dedicated to the development and marketing of clinical trial software and related services designed specifically for academic research and investigator initiated trials.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
target: Promasys BV
Promasys develops innovative software for clinical data management and clinical trial workflow support. Client focus is on academic research centers and hospitals, CRO's and SME pharmaceutical and biotech companies.
price ($mm)
$0.97
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2009 via PR Newswire

OmniComm Systems, Inc., purchased EDC Assets from Logos Technologies

synopsis: OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials announced that the company has acquired the EDC assets of UK based, clinical software provider, Logos Technologies, Ltd.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
seller: Logos Technologies
Logos Technologies is one of the early pioneers in providing world class solutions to pharmaceutical, contract research organisations and biotechnology companies with electronic data capture (EDC) and clinical management solutions needed to accelerate pharmaceutical research and development.
price ($mm)
$0.15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2009 via PR Newswire

OmniComm Systems, Inc., purchased EDC Solutions from eResearch Technology, Inc.

synopsis: OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, has acquired the EDC business of eResearchTechnology, Inc., a global provider of technology and services that enable life science industries worldwide to collect, interpret, and distribute cardiac safety and clinical data.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
seller: eResearch Technology, Inc.
eResearchTechnology, Inc. (eRT) is a provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently.
price ($mm)[EV]
$2.02 [$0.87]
rev ($mm)
$6
EBITDA ($mm)
EV / rev
0.1x
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
closed 10/3/2018 via BusinessWire

Anju Software, acquired Zephyr Health

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, announced that it has acquired San Francisco-based Zephyr Health, a company that provides comprehensive physician, institution and treatment data for every major disease area.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Zephyr Health
Founded in 2011, Zephyr Health is the leading insights-as-a-service company harnessing the power of global healthcare data for precise and confident product lifecycle performance for biopharmaceutical and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/21/2018 via BusinessWire

Anju Software, acquired MDCPartners

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Belgium-based MDCPartners, a company that specializes in business intelligence data solutions for clinical trial optimization, medical expert identification and competitive intelligence.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: MDCPartners
Based in Belgium, MDCPartners provides business intelligence solutions for clinical trial optimization, medical expert identification and competitive intelligence. MDC provides its clients with event-based tools to monitor and analyze an ever-expanding world of public and private data.
price ($mm)
rev ($mm)
$1,514
EBITDA ($mm)
$176
EV / rev
0.0x
EV / EBITDA
0.0x
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/31/2017 via BusinessWire

Anju Software, acquired ClinPlus

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired the assets of ClinPlus, a division of DZS Software Solutions, Inc. ClinPlus has a full suite of products used for the performance of clinical trials including EDC, IWRS, CTMS, eTMF, Data Management, Coding and SAS Reporting.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions with outstanding customer support. Anju was founded by a group of operating and investment professionals with deep software domain expertise. "
target parent: DZS Software Solutions, Inc.
target: ClinPlus
ClinPlus, a division of DZS Software Solutions, Inc., has a full suite of products used for the performance of clinical trials including EDC, IWRS, CTMS, eTMF, Data Management, Coding and SAS Reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/11/2017 via BusinessWire

Anju Software, acquired OpenQ

synopsis: Anju Software Inc., a life sciences software platform focused on delivering exceptional business application solutions with outstanding customer support, acquired OpenQ, a leading provider of Key Opinion Leader (KOL) data base and software solutions to manage KOLs. OpenQ has the largest suite of compliance solutions for regulated industries.
buyer: Anju Software
Anju Software is a life sciences software platform focused on delivering exceptional business application solutions with outstanding customer support. Anju was founded by a group of operating and investment professionals with deep domain expertise in the enterprise software sector. "
target: OpenQ
OpenQ enables social and mobile collaboration to create competitive advantage while overcoming compliance and exposure risks. OpenQ is a cloud-based technology and validated-data provider with the largest suite of life sciences- and healthcare-based compliance solutions on the market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2016 via BusinessWire

Anju Software, acquired Online Business Applications

synopsis: Anju Software, a life sciences software platform, announced that it has acquired Online Business Applications (OBA), a global provider of medical communication systems and drug safety compliance software for the pharmaceutical, biotechnology and medical device industries.
buyer: Anju Software
Anju Software is a life sciences software platform focused on delivering exceptional business application solutions with outstanding customer support. Anju was founded by a group of operating and investment professionals with deep domain expertise in the enterprise software sector. "
target: Online Business Applications
Online Business Applications has been developing software for medical information departments for over thirty years. Their software offers enhanced tools, including built-in custom reporting, document and correspondence management, FAQ Database, and built-in data and privacy protection.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
closed 9/1/2021 via BNC Analysis

Instem, acquired PDS Life Sciences

synopsis: Instem, a leading provider of IT solutions and services to the global life sciences market, has acquired PDS Life Sciences, a leading global provider of software and solutions for life sciences research and development. PDS offers SaaS solutions that make it simple for scientists to conduct toxicology, pathology and safety assessment research.
buyer: Instem (AIM:INS:$38.90)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
target: PDS Life Sciences
PDS Life Sciences is a leading global provider of software and solutions for life sciences research and development. PDS offers SaaS solutions that make it simple for scientists to conduct toxicology, pathology and safety assessment research that drives insightful decisions.
price ($mm)
$16
rev ($mm)
$7
EBITDA ($mm)
EV / rev
2.1x
EV / EBITDA
announced 8/18/2021 via BusinessWire

Verily Life Sciences, will acquire SignalPath

synopsis: Verily, an Alphabet company focused on life sciences and healthcare, will acquire SignalPath, a clinical trial management system (CTMS) that improves the ease and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
buyer parent: Google
buyer: Verily Life Sciences
Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily's mission is to make the world’s health data useful so that people enjoy healthier lives. The company develops tools to collect and activate health data, and creates interventions to prevent and manage disease. "
target: SignalPath
SignalPath is a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/7/2021 via BusinessWire

Francisco Partners Management LLC, will acquire STARLIMS

synopsis: Francisco Partners is to acquire the STARLIMS informatics product suite and related business assets from Abbott. A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
buyer: Francisco Partners Management LLC
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Francisco Partners has raised approximately $25 billion in committed capital and invested in more than 300 technology companies. "
target parent: Abbott Laboratories
target: STARLIMS (LIMS:$25.24)
A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/30/2021 via PR Newswire

Internet Brands, Inc., will acquire PulsePoint, Inc.

synopsis: Internet Brands will acquire PulsePoint Inc., a leading technology company using real-time data to unlock and activate health insights. Internet Brands' acquisition of PulsePoint accelerates its expansion into the healthcare marketing technology space, adding enhanced programmatic and data capabilities across its portfolio of companies.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: Internet Brands, Inc. (:$107.45)
Internet Brands is a fully integrated online media and software services organization focused on four vertical categories: Health, Automotive, Legal, and Home/Travel. Internet Brands' proprietary operating platform provides the flexibility and scalability to fuel the company's continued growth. "
target: PulsePoint, Inc.
PulsePoint is a leading technology company using real-time data to unlock and activate health insights. Through machine learning and programmatic automation, the company interprets the hard-to-read signals of the health journey to understand the connection points between relevance and engagement.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/1/2021 via BNC Analysis

DigiHealth Technologies LLP, will acquire Pharmarack Technologies Private Limited

synopsis: DigiHealth Technologies LLP will acquire 100 per cent stake in Pharmarack Technologies Pvt Ltd. Pharmarack operates a digital platform aimed at integrating and solving problems across the pharmaceutical supply chain. Pharmarack is India’s largest integrated B2B healthcare tech platform.
buyer: DigiHealth Technologies LLP
DigiHealth, based in India, is an all-in-one mobile app for pharmacy needs. The mobile app provides benefits and enables the users to order medicines online from their local pharmacy, book diagnostic lab tests, and set up automatic refills. "
target: Pharmarack Technologies Private Limited
Pharmarack, based in India, operates a digital platform aimed at integrating and solving problems across the pharmaceutical supply chain. Pharmarack is India’s largest integrated B2B healthcare tech platform – offering SaaS Solutions, Delivery Enablement, Financing Solutions, and more.
price ($mm)
$15*
rev ($mm)
$0
EBITDA ($mm)
EV / rev
298.6x
EV / EBITDA
closed 3/1/2021 via BusinessWire

Instem, acquired The Edge Software Consultancy Ltd.

synopsis: Instem, a leading provider of IT solutions and services to the global life sciences market, has acquired The Edge Software Consultancy Ltd., a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development.
buyer: Instem (AIM:INS:$38.90)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
target: The Edge Software Consultancy Ltd.
The Edge is a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development. Their BioRails platform enables automated data capture over the entire research and development process.
price ($mm)
$7.88
rev ($mm)
$3
EBITDA ($mm)
EV / rev
3.1x
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/11/2021 via Yahoo, Inc.

RxE2, will acquire Habitu Health

synopsis: RxE2, which is bringing the practice of pharmacy to clinical research, has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes.
buyer: RxE2
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists to make clinical trials more accessible to patients, everywhere. "
target: Habitu Health
Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes by providing real-time analyses of a more comprehensive set of patient data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2020 via Company Press Release

ZEISS Group, acquired Arivis

synopsis: ZEISS, an international technology enterprise operating in the fields of optics and optoelectronics, has acquired a majority stake in arivis, a biomedical software company in Germany. arivis enables users to visualize and manage multi-dimensional image datasets. Their platform features solutions for imaging, compliance, data management, and more.
buyer: ZEISS Group (XTRA:AFX:$1,364.13)
ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. The ZEISS Group develops, produces and distributes measuring technology, microscopes, medical technology, eyeglass lenses, camera and cinema lenses, binoculars and more. "
target: Arivis
arivis is a biomedical big image data and compliance software company in Germany. arivis enables users to visualize, analyze, distribute and manage multi-terabyte, multi-dimensional image datasets. Their cloud-based platform features solutions for imaging, compliance, data management, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/25/2020 via Company Press Release

Advarra, acquired Longboat Clinical Ltd.

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Longboat Clinical Ltd.
Longboat is an innovative provider of user-friendly, fully mobile clinical research technology solutions that take the complexity out of trials for site staff, patients, monitors, and study teams, making protocol compliance easy and instinctive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/8/2020 via BNC Analysis

bigtincan, will acquire Agnitio A/S

synopsis: Bigtincan Holdings Limited, a leader in sales enablement automation, will acquire Agnitio A/S, a Danish provider of customer engagement software for the life sciences industry. Agnitio's Rainmaker solution is a multichannel software platform that enables pharma and medical device companies to better engage healthcare professionals and payers.
buyer: bigtincan (ASX:BTH:$22.22)
Bigtincan helps sales and service teams increase win rates and customer satisfaction. The company’s mobile, AI-powered sales enablement automation platform features the industry’s premier user experience that empowers reps to more effectively engage with customers and encourages team-wide adoption. "
target: Agnitio A/S
Agnitio is a Danish provider of customer engagement software for the life sciences industry. Agnitio's Rainmaker solution is a multichannel software platform that enables pharma and medical device companies to better engage healthcare professionals, payers and other life science stakeholders.
price ($mm)
$2.34
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2020 via Company Press Release

Cytel Inc., acquired Laiya Consulting, Inc.

synopsis: Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation. Laiya pioneered the delivery of trial design software using SaaS, which aligns with Cytel’s goal of making all of its design software available as a cloud-based service.
buyer parent: New Mountain Capital, LLC
buyer: Cytel Inc.
Cytel provides statistical software for clinical trials. Cytel provides an understanding of software tools that solve statistical problems and that meet the highest standards of reliability, technical documentation and customer support. "
target: Laiya Consulting, Inc.
Founded in 2010, Laiya Consulting has supported drug developers to drive success rates and maximize portfolio returns through the design and implementation of Bayesian adaptive trials, robust clinical strategies, and integrated software platforms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/21/2020 via PR Newswire

Elsevier B.V., acquired SciBite

synopsis: Elsevier, a global research publishing and information analytics provider, and part of RELX, has acquired SciBite, a semantic AI company headquartered in Cambridge, UK, to help customers make faster, more effective R&D decisions through advanced text and data intelligence solutions.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers and tackle human crises. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education. "
target: SciBite
SciBite offer a complete semantic services platform for life sciences that can be used as a data analytics solution by end users and also as a 'pluggable' component to transform existing IT infrastructures into more scientifically aware systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/21/2020 via PR Newswire

HealthVerity, acquired Curisium

synopsis: HealthVerity, the leader in privacy-protected data exchange, announced that it has acquired Curisium, an innovator in cloud-based drug rebate processing and contract performance management.
buyer: HealthVerity
HealthVerity has emerged as a leader and key partner to nearly 75% of top pharmaceutical manufacturers and payers, having fundamentally changed the way that key healthcare organizations secure, exchange and synthesize HIPAA-protected information at scale. "
target: Curisium
Curisium is an innovator in cloud-based drug rebate processing and contract performance management. Curisium's cutting-edge platform enables payers, pharmaceutical manufacturers and providers to enter into innovative contracting arrangements in a secure, efficient, scalable, data-driven way.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/10/2020 via BNC Analysis

Antares Vision, will acquire TradeTicity

synopsis: Antares Vision, the worldwide leading supplier of inspection and serialization systems for the pharmaceutical industry, will acquire an 82.83% stake in TradeTicity, a Croatian provider of serialization solutions for pharmaceutical companies. TradeTicity's CureSync is a cloud-based software solution that simplifies the serialization process.
buyer: Antares Vision (BIT:AV:$147.74)
Antares Vision is the worldwide leading supplier of inspection and serialization systems for the pharmaceutical industry. Antares Vision designs and produces the most advanced Inspection, Track & Trace and Smart Data Management solutions on the market completely tailored to individual product needs."
target: TradeTicity
TradeTicity is a Croatian provider of serialization solutions for pharmaceutical companies. TradeTicity's CureSync is a cloud-based software solution that simplifies the serialization process. CureSync covers all levels of serialization and handles billions of serialization codes.
price ($mm)
$1.12*
rev ($mm)
$1
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like OmniComm Systems, Inc.


read more

OmniComm Systems, Inc.

SignalPath

STARLIMS

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

Habitu Health

Viedoc

Clinical Trial Connect, LLC

Forte Research Systems

THREAD Research

Medidata

Custodix N.V.

GoBalto

Sylogent

Parallel 6

SecureConsent

Clinverse, Inc.

Medsight Solutions Inc.

e-novex

read more

OmniComm Systems, Inc.

Algorics

Promasys BV

Logos Technologies

eResearch Technology, Inc.

read more

OmniComm Systems, Inc.

Zephyr Health

MDCPartners

Sylogent

ClinPlus

OpenQ

Online Business Applications

read more

OmniComm Systems, Inc.

PDS Life Sciences

SignalPath

STARLIMS

MedSciNet

Greenphire, Inc

PulsePoint, Inc.

Pharmarack Technologies Private Limited

The Edge Software Consultancy Ltd.

TrialTech Medical Inc.

Habitu Health

Arivis

Longboat Clinical Ltd.

Envision Pharma Group

Agnitio A/S

Laiya Consulting, Inc.

SciBite

Curisium

TradeTicity

Viedoc

Geography
Matching Companies
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2020
rev ($mm)
$15.41
EBITDA ($mm)
($7.76)
EBIT ($mm)
($7.93)
Net Income ($mm)
Employees
163
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.90
EBITDA ($mm)
$6.31
EBIT ($mm)
$5.20
Net Income ($mm)
$3.13
Employees
304
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: VEEV
 
 
 
 
 
 
 
 
Veeva Systems
Veeva Systems
Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 300 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs.
year
2021
rev ($mm)
$1,561.54
EBITDA ($mm)
$446.88
EBIT ($mm)
$418.68
Net Income ($mm)
$409.00
Employees
4506
  • drill down
  • watch
Ticker: MODN
 
 
 
 
 
 
 
 
Model N, Inc.
Model N, Inc.
Model N is the pioneer and leading provider of Revenue Management cloud solutions for the Life Sciences and High Technology industries. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities.
year
2016
rev ($mm)
$106.97
EBITDA ($mm)
($26.81)
EBIT ($mm)
($32.74)
Net Income ($mm)
Employees
814
  • drill down
  • watch
Ticker: BSE:540654
 
 
 
 
 
 
 
 
GlobalSpace Technologies Limited
GlobalSpace Technologies Limited
GlobalSpace Technologies is a provider of sales force enhancement solutions to the Indian pharma industry. GlobalSpace's GloDigitAll solution supports businesses in the digitalization of their sales and marketing processes. Their GloKIOSK solution allows businesses to acquire and educate customers.
year
2018
rev ($mm)
$4.28
EBITDA ($mm)
$0.64
EBIT ($mm)
$0.62
Net Income ($mm)
$0.34
Employees
88
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ASX:CGL
 
 
 
 
 
 
 
 
Citadel Group Limited
Citadel Group Limited
Citadel is a leading Australian technology and software company that specialise in secure enterprise information management in complex environments. Citadel provides secure information to support real-time decisions across the Health, National Security and Defence industries.
year
2019
rev ($mm)
$73.75
EBITDA ($mm)
$10.86
EBIT ($mm)
$8.04
Net Income ($mm)
$4.10
Employees
180
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: CRW.L
 
 
 
 
 
 
 
 
Craneware, Inc.
Craneware, Inc.
Craneware, based in Scotland, is the leader in automated revenue integrity solutions that improve financial performance for healthcare organizations. Its SaaS solutions help and healthcare providers effectively price, charge, and code for services and supplies associated with patient care.
year
2012
rev ($mm)
$42.44
EBITDA ($mm)
$12.06
EBIT ($mm)
$10.80
Net Income ($mm)
$9.43
Employees
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2020
rev ($mm)
$15.41
EBITDA ($mm)
($7.76)
EBIT ($mm)
($7.93)
Net Income ($mm)
Employees
163
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch